Affect Therapeutics
PrivateLast Round
Series B
Nov 5, 2025
Total Funding Raised
$75.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Affect Therapeutics is a digital health company that provides a smartphone-based virtual clinic for substance use and mental health disorders, utilizing contingency management, counseling, and medication-assisted treatment.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Telemedicine, Patient Engagement
Business Model
B2B2C
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Affect Therapeutics Comparables
Compare Affect Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| WEconnect Health Management | 82% | |
| Workit Health | 81% | |
| Monument | 80% |
Affect Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 5, 2025 | ||||
| Series B | Sep 23, 2025 | ||||
| Series A | Jul 12, 2023 | ||||
| Grant | Sep 30, 2021 | ||||
| Seed | Aug 31, 2021 | ||||
Seed | Apr 21, 2021 |
Key People
Founding team and executive leadership
Affect Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AlleyCorp | Seed, Series A |
| ARTIS Ventures | Series B, Series A |
| Allumia Ventures | Series B |
| Samsung Next TLV | Series A |
| LifeArc Ventures | Series B, Series A |
| Kapor Capital | Seed |
| Acumen | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 5, 2026
Monthly visitors increased 141% MoM.
- Sep 23, 2025
$26M round led by Allumia Ventures.
Affect Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Affect Therapeutics's valuation, stock price, and market status.
Is Affect Therapeutics a public or private company?
Affect Therapeutics is a private company.
What is the current stock price of Affect Therapeutics?
Affect Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Affect Therapeutics worth (valuation)?
Valuation information for Affect Therapeutics is not publicly available.
Can I buy Affect Therapeutics stock?
Affect Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Affect Therapeutics's last funding round?
Affect Therapeutics's most recent funding round was Series B on November 5, 2025.
Who are the main investors in Affect Therapeutics?
Key investors in Affect Therapeutics include ARTIS Ventures, Allumia Ventures.
Will Affect Therapeutics IPO soon?
No public IPO plans have been announced for Affect Therapeutics.
How can I track Affect Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Affect Therapeutics's secondary market activity and sign up for updates.